• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性和 PSEN1 A431E 相关家族性阿尔茨海默病患者脑脊液中淀粉样β肽特征明显不同。

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.

机构信息

Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.

出版信息

Mol Neurodegener. 2010 Jan 14;5:2. doi: 10.1186/1750-1326-5-2.

DOI:10.1186/1750-1326-5-2
PMID:20145736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2818651/
Abstract

BACKGROUND

Alzheimer's disease (AD) is associated with deposition of amyloid beta (Abeta) in the brain, which is reflected by low concentration of the Abeta1-42 peptide in the cerebrospinal fluid (CSF). There are at least 15 additional Abeta peptides in human CSF and their relative abundance pattern is thought to reflect the production and degradation of Abeta. Here, we test the hypothesis that AD is characterized by a specific CSF Abeta isoform pattern that is distinct when comparing sporadic AD (SAD) and familial AD (FAD) due to different mechanisms underlying brain amyloid pathology in the two disease groups.

RESULTS

We measured Abeta isoform concentrations in CSF from 18 patients with SAD, 7 carriers of the FAD-associated presenilin 1 (PSEN1) A431E mutation, 17 healthy controls and 6 patients with depression using immunoprecipitation-mass spectrometry. Low CSF levels of Abeta1-42 and high levels of Abeta1-16 distinguished SAD patients and FAD mutation carriers from healthy controls and depressed patients. SAD and FAD were characterized by similar changes in Abeta1-42 and Abeta1-16, but FAD mutation carriers exhibited very low levels of Abeta1-37, Abeta1-38 and Abeta1-39.

CONCLUSION

SAD patients and PSEN1 A431E mutation carriers are characterized by aberrant CSF Abeta isoform patterns that hold clinically relevant diagnostic information. PSEN1 A431E mutation carriers exhibit low levels of Abeta1-37, Abeta1-38 and Abeta1-39; fragments that are normally produced by gamma-secretase, suggesting that the PSEN1 A431E mutation modulates gamma-secretase cleavage site preference in a disease-promoting manner.

摘要

背景

阿尔茨海默病(AD)与脑内淀粉样β(Abeta)沉积有关,这反映在脑脊液(CSF)中 Abeta1-42 肽浓度较低。人类 CSF 中至少还有 15 种额外的 Abeta 肽,它们的相对丰度模式被认为反映了 Abeta 的产生和降解。在这里,我们检验了这样一个假设,即 AD 的特征是一种特定的 CSF Abeta 同工型模式,由于两组疾病中脑淀粉样病理学的潜在机制不同,当比较散发性 AD(SAD)和家族性 AD(FAD)时,这种模式是不同的。

结果

我们使用免疫沉淀-质谱法测量了 18 例 SAD 患者、7 例携带 FAD 相关早老素 1(PSEN1)A431E 突变的携带者、17 名健康对照者和 6 例抑郁症患者的 CSF 中 Abeta 同工型浓度。CSF 中 Abeta1-42 水平较低和 Abeta1-16 水平较高可将 SAD 患者和 FAD 突变携带者与健康对照者和抑郁症患者区分开来。SAD 和 FAD 的 Abeta1-42 和 Abeta1-16 均有类似的变化,但 FAD 突变携带者的 Abeta1-37、Abeta1-38 和 Abeta1-39 水平非常低。

结论

SAD 患者和 PSEN1 A431E 突变携带者的 CSF Abeta 同工型模式异常,具有临床相关的诊断信息。PSEN1 A431E 突变携带者的 Abeta1-37、Abeta1-38 和 Abeta1-39 水平较低;这些片段通常是由 γ-分泌酶产生的,这表明 PSEN1 A431E 突变以促进疾病的方式调节 γ-分泌酶切割位点的偏好。

相似文献

1
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.散发性和 PSEN1 A431E 相关家族性阿尔茨海默病患者脑脊液中淀粉样β肽特征明显不同。
Mol Neurodegener. 2010 Jan 14;5:2. doi: 10.1186/1750-1326-5-2.
2
The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease.家族性 PSEN1 M139T-和 L286P 相关阿尔茨海默病患者脑脊液中淀粉样β 异构体模式。
Mol Med Rep. 2012 Apr;5(4):1111-5. doi: 10.3892/mmr.2012.774. Epub 2012 Feb 1.
3
Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease.脑淀粉样β 异构体特征的质谱分析在家族性和散发性阿尔茨海默病中的作用。
Acta Neuropathol. 2010 Aug;120(2):185-93. doi: 10.1007/s00401-010-0690-1. Epub 2010 Apr 24.
4
Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.源自散发性阿尔茨海默病 iPSC 的神经元显示出 TAU 过度磷酸化增加、淀粉样蛋白水平升高和 GSK3β 激活。
Alzheimers Res Ther. 2017 Dec 1;9(1):90. doi: 10.1186/s13195-017-0317-z.
5
Amyloid-β cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations.淀粉样蛋白-β 脑脊液水平与 APP、PSEN1 和 PSEN2 突变的解读。
Alzheimers Res Ther. 2020 Sep 11;12(1):108. doi: 10.1186/s13195-020-00676-5.
6
Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.支持和反对γ-分泌酶活性降低在家族性阿尔茨海默病中致病作用的证据
J Alzheimers Dis. 2016 Apr 4;52(3):781-99. doi: 10.3233/JAD-151186.
7
PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.PSEN1 突变携带者的脑脊液淀粉样蛋白-β42 水平低于散发性早发性阿尔茨海默病患者,但神经元损伤生物标志物无差异。
J Alzheimers Dis. 2012;30(3):605-16. doi: 10.3233/JAD-2012-111949.
8
Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.γ-分泌酶抑制对阿尔茨海默病小鼠模型中淀粉样β 异构体模式的影响。
Neurodegener Dis. 2009;6(5-6):258-62. doi: 10.1159/000264639. Epub 2009 Dec 3.
9
Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.携带早老素家族性阿尔茨海默病突变的受试者表现出多种白质生物化学改变。
Am J Neurodegener Dis. 2013 Sep 18;2(3):187-207. eCollection 2013.
10
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.阿尔茨海默病、路易体痴呆和帕金森病痴呆中的脑脊液淀粉样β肽。
Brain. 2006 May;129(Pt 5):1177-87. doi: 10.1093/brain/awl063. Epub 2006 Apr 6.

引用本文的文献

1
Reduced protein solubility - cause or consequence in amyloid disease?蛋白质溶解度降低——是淀粉样疾病的原因还是结果?
QRB Discov. 2025 Feb 17;6:e8. doi: 10.1017/qrd.2024.12. eCollection 2025.
2
The duality of amyloid-β: its role in normal and Alzheimer's disease states.淀粉样蛋白-β的双重性:在正常和阿尔茨海默病状态中的作用。
Mol Brain. 2024 Jul 17;17(1):44. doi: 10.1186/s13041-024-01118-1.
3
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.常染色体显性遗传与散发性早发型阿尔茨海默病的分子神经影像学

本文引用的文献

1
Aspects of beta-amyloid as a biomarker for Alzheimer's disease.β-淀粉样蛋白作为阿尔茨海默病生物标志物的相关方面。
Biomark Med. 2007 Jun;1(1):59-78. doi: 10.2217/17520363.1.1.59.
2
A novel pathway for amyloid precursor protein processing.一种淀粉样前体蛋白加工的新途径。
Neurobiol Aging. 2011 Jun;32(6):1090-8. doi: 10.1016/j.neurobiolaging.2009.06.002. Epub 2009 Jul 14.
3
Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization.淀粉样β蛋白:β淀粉样蛋白40抑制β淀粉样蛋白42寡聚化。
Brain Commun. 2024 May 3;6(3):fcae159. doi: 10.1093/braincomms/fcae159. eCollection 2024.
4
The supersaturation perspective on the amyloid hypothesis.淀粉样蛋白假说的过饱和观点。
Chem Sci. 2023 Oct 16;15(1):46-54. doi: 10.1039/d3sc03981a. eCollection 2023 Dec 20.
5
Heterotypic Interactions between the 40- and 42-Residue Isoforms of β-Amyloid Peptides on Lipid Bilayer Surfaces.β-淀粉样肽的 40 位和 42 位异构体在脂质双分子层表面的异型相互作用。
ACS Chem Neurosci. 2023 Dec 6;14(23):4153-4162. doi: 10.1021/acschemneuro.3c00523. Epub 2023 Nov 22.
6
< Variant and Early-Onset Alzheimer's Disease: A Scoping Review.< 变异型和早发型阿尔茨海默病:一项范围综述。
Front Aging Neurosci. 2022 Jul 22;14:860529. doi: 10.3389/fnagi.2022.860529. eCollection 2022.
7
γ-Secretase in Alzheimer's disease.γ-分泌酶在阿尔茨海默病中的作用。
Exp Mol Med. 2022 Apr;54(4):433-446. doi: 10.1038/s12276-022-00754-8. Epub 2022 Apr 8.
8
Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation.淀粉样β肽37、38和40分别及协同抑制淀粉样β42聚集。
Chem Sci. 2022 Feb 7;13(8):2423-2439. doi: 10.1039/d1sc02990h. eCollection 2022 Feb 23.
9
Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease.脑脊液中 Aβ37/42 肽比值作为阿尔茨海默病 Aβ标志物的改进。
Alzheimers Dement. 2023 Jan;19(1):79-96. doi: 10.1002/alz.12646. Epub 2022 Mar 12.
10
Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis.长期给予咖啡因治疗阿尔茨海默病小鼠模型可改善行为缺陷和神经元丢失,并促进神经发生的细胞和分子标志物。
Cell Mol Life Sci. 2021 Dec 16;79(1):55. doi: 10.1007/s00018-021-04062-8.
J Am Chem Soc. 2009 May 13;131(18):6316-7. doi: 10.1021/ja8092604.
4
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.阿尔茨海默病中的突触逆行发生与β-淀粉样蛋白
J Alzheimers Dis. 2009;16(1):1-14. doi: 10.3233/JAD-2009-0918.
5
The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.淀粉样前体蛋白40(Abeta40)和淀粉样前体蛋白42(Abeta42)的单体形式与聚集形式的比例是β淀粉样蛋白聚集、纤维形成和毒性的重要决定因素。
J Biol Chem. 2008 Oct 17;283(42):28176-89. doi: 10.1074/jbc.M803159200. Epub 2008 Aug 11.
6
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.阿尔茨海默病的核心候选神经化学和成像生物标志物。
Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21.
7
Biochemical markers in persons with preclinical familial Alzheimer disease.临床前家族性阿尔茨海默病患者的生化标志物。
Neurology. 2008 Jul 8;71(2):85-92. doi: 10.1212/01.wnl.0000303973.71803.81. Epub 2008 May 28.
8
Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.阿尔茨海默病中的靶向蛋白质组学:聚焦于β-淀粉样蛋白
Expert Rev Proteomics. 2008 Apr;5(2):225-37. doi: 10.1586/14789450.5.2.225.
9
Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.含淀粉样β蛋白二聚体的人脑脊液会破坏突触可塑性:全身被动免疫可预防
J Neurosci. 2008 Apr 16;28(16):4231-7. doi: 10.1523/JNEUROSCI.5161-07.2008.
10
Amyloid-related biomarkers for Alzheimer's disease.阿尔茨海默病的淀粉样蛋白相关生物标志物。
Curr Med Chem. 2008;15(8):766-71. doi: 10.2174/092986708783955572.